MarketBeat Highlights Three Penny Stocks Under $5 With Real Revenue Growth

Industry
โดย MarketBeat·Read original
Summary · why it matters

MarketBeat identifies three penny stocks trading below $5 that generate real revenue and have catalysts for future growth. Ur-Energy, a uranium miner using in situ recovery techniques, is expected to turn profitable in the second half of 2026 as its Shirley Basin project ramps up, with six analysts setting a consensus price target of $2.57. Grab Holdings operates a super app in Southeast Asia and has been profitable, but its stock is down over 20% in the last 12 months, though ten analysts see significant upside ahead. Aclaris Therapeutics has no assets beyond Phase 2 trials but receives licensing revenue from Eli Lilly and Sun Pharma, and eight analysts have a consensus price target over 150% above the current stock price.

Impact on stocks 4

Biotech & Genomic Medicine▲ · 2 stocks
Aclaris Therapeutics Inc
ACRS
± MixedCapitalrelevance

Analyst consensus price target over 150% above current price, but company has no assets beyond Phase 2 trials and relies on licensing revenue.

Digital Finance & Tokenization▲ · 1 stocks
Grab Holdings Ltd
GRAB
± MixedCapitalrelevance

Stock down over 20% in 12 months but ten analysts see significant upside; profitable super app operator.

Critical Materials & Supply Chain▲ · 1 stocks
Ur Energy Inc
URG
▲ PositiveCapitalrelevance

Expected to turn profitable in H2 2026 as Shirley Basin ramps up; six analysts set consensus price target of $2.57.

© 2026 MarketDXNews